Safety and efficacy of adefovir therapy for lamivudine-resistant hepatitis B virus infection in renal transplant recipients

Safety and efficacy of adefovir therapy for lamivudine-resistant hepatitis B virus infection in renal transplant recipients

The emergence of lamivudine (LAM)-resistant mutants after prolonged LAM therapy may reduce its therapeutic effects against hepatitis B virus (HBV). Adefovir dipivoxil (ADV) is an effective treatment of LAM-resistant HBV infections. However, only limited data are available regarding the safety and ef...

Full description

Bibliographic Details
Main Authors:	Hsin-Wu Lai, Chiu-Chun Chang, Tan-Hsia Chen, Ming-Chang Tsai, Tzy-Yen Chen, Chun-Che Lin
Format:	Article
Language:	English
Published:	Elsevier 2012-08-01
Series:	Journal of the Formosan Medical Association
Subjects:	adefovir dipivoxil hepatitis B surface antigen lamivudine resistance nephrotoxicity renal transplant recipient
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664612000587

Similar Items

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus
by: Hyun Young Woo, et al.
Published: (2014-06-01)

Virologic Response at 12 Months of Treatment Predicts Sustained Antiviral Efficacy in Patients with Adefovir-Treated Lamivudine-Resistant Chronic Hepatitis B
Published: (2010-06-01)

Comparison of the antiviral effects of different nucleos(t)ide analogues in chinese patients with chronic hepatitis B: A head-to-head study
by: Shu Yu, et al.
Published: (2014-01-01)

Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis
by: Hu Peng, et al.
Published: (2011-08-01)

Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
by: Hyun Young Woo, et al.
Published: (2020-07-01)

Low-dose adefovir dipivoxil–induced hypophosphatemia osteomalacia in five chronic hepatitis B virus–infected patients. Is low-dose adefovir dipivoxil–induced nephrotoxicity completely reversible?
by: Qian YY, et al.
Published: (2019-04-01)

Adefovir dipivoxil inhibits APL progression through degradation of the oncoprotein PML-RARA
by: Xubo Gong, et al.
Published: (2022-11-01)

Pathological Femoral Fracture due to Osteoporosis and Hypophosphatemic Osteomalacia Following Adefovir Therapy in a Patient with Chronic Hepatitis B
by: Sevilay Batıbay, et al.
Published: (2018-08-01)

Optimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-Year prospective study
by: Zhang Jing, et al.
Published: (2011-09-01)

Factors Predicting the Efficacy of Adefovir Dipivoxil on Treatment-Na?ve Chronic Hepatitis B Patients at 48 Weeks
Published: (2011-12-01)

A Low Viral Load Predicts a Higher Initial Virologic Response to Adefovir in Patients with Lamivudine-Resistant Chronic Hepatitis B
Published: (2010-12-01)

Adefovir dipivoxil-induced development of osteomalacia and Fanconi syndrome during the treatment of hepatitis B virus (HBV)-related cirrhosis
by: Orietta Staltari, et al.
Published: (2014-12-01)

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?
by: Byung-Cheol Song
Published: (2016-12-01)

Adefovir dipivoxil nella terapia dell’epatite B cronica: profilo farmacologico clinico ed economico
by: Lorenzo Pradelli, et al.
Published: (2005-12-01)

Liquid-Assisted Grinding to Prepare a Cocrystal of Adefovir Dipivoxil Thermodynamically Less Stable than Its Neat Phase
by: Sungyup Jung, et al.
Published: (2015-11-01)

Eficácia do adefovir dipivoxil, entecavir e telbivudina para o tratamento da hepatite crônica B: revisão sistemática The efficacy of adefovir dipivoxil, entecavir and telbivudine for chronic hepatitis B treatment: a systematic review
by: Alessandra Maciel Almeida, et al.
Published: (2010-08-01)

Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report
by: Tanaka Motoyuki, et al.
Published: (2012-08-01)

Fanconi syndrome due to prolonged use of low-dose adefovir
by: Xiao-Bing Wang, et al.
Published: (2015-01-01)

Effect of Adefovir Dipivoxil on the Inhibition of Osteogenic Differentiation of Mesenchymal Stem Cells and Osteoblasts
by: Ho PARK
Published: (2023-12-01)

Melting Diagrams of Adefovir Dipivoxil and Dicarboxylic Acids: An Approach to Assess Cocrystal Compositions
by: Hyunseon An, et al.
Published: (2019-01-01)

Management of intraoperative periprosthetic fractures in a patient with osteomalacia induced by chronic use of adefovir dipivoxil: A good treatment outcome with a 5-year follow-up
by: Yingwei Bi, et al.
Published: (2023-12-01)

Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
Published: (2013-05-01)

Management of Antiviral Resistance in Chronic Hepatitis B
by: Young-Suk Lim
Published: (2017-03-01)

Long-Term Outcomes and Dynamics of Mutants Associated with Lamivudine-Adefovir Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B
Published: (2015-01-01)

Lamivudine for chronic hepatitis B: a brief review
by: Emilio Palumbo

Fanconi's Syndrome Associated with Prolonged Adefovir Dipivoxil Therapy in a Hepatitis B Virus Patient
Published: (2010-09-01)

Hypophosphatemia Due to Adefovir Treatment
by: Nazlım AKTUĞ DEMİR, et al.
Published: (2012-12-01)

Lamivudine therapy for hepatitis B in renal transplantation
by: F.R.L. Santos, et al.
Published: (2002-02-01)

Treatment of chronic hepatitis B in Oman experience with lamivudine
by: Upadhyay Dip Amal, et al.
Published: (2003-01-01)

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
by: Chan Ho Park, et al.
Published: (2016-03-01)

Drug-induced Fanconi syndrome in patients with kidney allograft transplantation
by: Zhouqi Tang, et al.
Published: (2022-08-01)

Multiple-level spinal fractures due to adefovir-induced Fanconi syndrome and hypophosphatemic osteomalacia: A case report
by: Haichao He, et al.
Published: (2023-04-01)

Rhabdomyolysis due to Lamivudine administration in acute viral hepatitis B infection: a case report from Malaysia
by: Janudin Baharin, et al.
Published: (2014-03-01)

Adefovir-induced Fanconi syndrome associated with osteomalacia
by: Samel Park, et al.
Published: (2018-09-01)

Prevention by Lamivudine of Hepatocellular Carcinoma in Patients Infected with Hepatitis B Virus
Published: (2007-12-01)

Lamivudine and Entecavir for Acute Hepatitis B: A Systematic Review and Meta-Analysis
by: Cesar Henriquez-Camacho, et al.
Published: (2023-11-01)

Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
by: Jurgen Gerada, et al.
Published: (2013-06-01)

Predictive factors for response to Lamivudine in chronic hepatitis B
by: Luiz Caetano da SILVA, et al.
Published: (2000-08-01)

Complete Remission of Nephrotic Syndrome of Hepatitis B Virus-associated Membranous Glomerulopathy After Lamivudine Monotherapy
by: Tang-Wei Chuang, et al.
Published: (2007-10-01)

Tenofovir Alafenamide Rescues Renal Tubules in Patients with Chronic Hepatitis B
by: Tomoya Sano, et al.
Published: (2021-03-01)